Eli Lilly has filed three new separate lawsuits accusing vendors and a medical spa of selling knock-off versions of their ...

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval ...

The sellers of these online products acknowledge that many of their drugs are for ‘research purposes only’ or ‘not for human ...

Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

Waldron Private Wealth LLC decreased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the 3rd ...

Leo Wealth LLC lowered its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 17.7% during the third ...

The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for ...

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Amid ongoing legal battles over coveted GLP-1 therapies, a drug vendor in Washington state is accused of running an ...